Intranasal Administration of Self-Oriented Nanocarriers Based on Therapeutic Exosomes for Synergistic Treatment of Parkinson’s Disease-Reference-Cited by-同舟云学术

Intranasal Administration of Self-Oriented Nanocarriers Based on Therapeutic Exosomes for Synergistic Treatment of Parkinson’s Disease

Published:2022-01-05 Issue:1 Volume:16 Page:869-884
ISSN:1936-0851
Container-title:ACS Nano
language:en
Short-container-title:ACS Nano

Author:

Peng Huan¹²,Li Yan³,Ji Weihong¹²,Zhao Ruichen¹²,Lu Zhiguo¹²,Shen Jie¹²,Wu Yanyue¹²,Wang Jianze¹,Hao Qiulian¹,Wang Jingwen¹,Wang Wenli¹,Yang Jun¹²,Zhang Xin¹²^ORCID

Affiliation:

1. State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, PR China

2. University of Chinese Academy of Sciences, Beijing 100049, PR China

3. School of Chemistry and Biological Engineering, University of Science and Technology Beijing, Beijing 100083, PR China

Funder

Natural Science Foundation of Beijing Municipality

National Natural Science Foundation of China

Beijing Nova Program

Publisher

American Chemical Society (ACS)

Subject

General Physics and Astronomy,General Engineering,General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/acsnano.1c08473

Reference49 articles.

1. Parkinson's disease

2. The role of α-synuclein in Parkinson's disease: insights from animal models

3. Inflammation is genetically implicated in Parkinson’s disease

4. Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations

5. Missing pieces in the Parkinson's disease puzzle

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rational design of siRNA-based delivery systems for effective treatment of brain diseases;Pharmaceutical Science Advances;2024-12

2. Mesenchymal stem cell-derived exosomes as cell free nanotherapeutics and nanocarriers;Nanomedicine: Nanotechnology, Biology and Medicine;2024-10

3. Toward the Integration of Machine Learning and Molecular Modeling for Designing Drug Delivery Nanocarriers;Advanced Materials;2024-09-10

4. Research Progress on the Strategies for Crossing the Blood–Brain Barrier;Molecular Pharmaceutics;2024-09-04

5. Hybrid nanostructures for neurodegenerative disease theranostics: the art in the combination of biomembrane and non-biomembrane nanostructures;Translational Neurodegeneration;2024-08-27